Sagimet Biosciences Inc.
SGMT
Revenue
2.00M
0.000.00%
2 Months ChangeAssets
189.02M
▼-5.51M▼-2.83%
3 Months ChangeLiabilities
5.73M
▲1.22M▲27.01%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-16
Form 8-K
ID: 0001104659-24-090546
2024-08-14
Form 8-K
ID: 0001104659-24-089340
2024-08-14
Form 10-Q
ID: 0001558370-24-012136
2024-08-01
Form 8-K
ID: 0001104659-24-084645
2024-07-02
Form 8-K
ID: 0001104659-24-077430
2024-06-06
Form 8-K
ID: 0001104659-24-068817
2024-05-23
Form 8-K
ID: 0001104659-24-064509
2024-05-15
Form 8-K
ID: 0001104659-24-061609
2024-05-15
Form 10-Q
ID: 0001558370-24-008205
2024-05-06
Form 8-K
ID: 0001104659-24-057228